Gilead Sciences Inc (NASDAQ:GILD)
| 62.37 Delayed Data As of Jul 01 |  +0.56 / +0.91%Today’s Change | 57.17 Today|||52-Week Range 74.12 | -14.10% Year-to-Date |
Latest GILD News | Press Releases
Today’s Trading
| Previous close | 61.81 |
| Today’s open | 61.57 |
| Day’s range | 61.27 - 62.42 |
| Volume | 374,101 |
| Average volume (3 months) | 9,194,302 |
| Market cap | $78.2B |
Data as of 4:00pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +4,962.51% |
| Earnings growth (this year) | -10.21% |
| Earnings growth (next 5 years) | +0.10% |
| Revenue growth (last year) | +11.08% |
| P/E ratio | 17.4 |
| Price/Sales | 3.35 |
| Price/Book | 3.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | +7.13 | +4.99% |
| BIIBBiogen | +6.70 | +3.29% |
| ILMNIllumina Inc | +6.67 | +3.62% |
| AMGNAmgen | +2.15 | +0.88% |
Data as of 5:10pm ET, 07/01/2022
Financials
| Next reporting date | July 27, 2022 |
| EPS forecast (this quarter) | $1.51 |
| Annual revenue (last year) | $27.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 22.74% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
